Ashley Webster
Women's Health · Asheboro, NCNPI 1891172904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,231 and has fallen 78.8% since, to $261 in 2025. Among women's health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$597
- Novo Nordisk$414
- Merz North America, Inc.$242
- Lilly USA, LLC$233
- AstraZeneca$162
- Galderma Laboratories, L.p.$153
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $597 |
| Novo Nordisk | 26 | $414 |
| Merz North America, Inc. | 3 | $242 |
| Lilly USA, LLC | 12 | $233 |
| AstraZeneca | 10 | $162 |
| Galderma Laboratories, L.p. | 3 | $153 |
| Biohaven Pharmaceuticals, Inc. | 4 | $78 |
| Merck | 4 | $72 |
| Novartis | 4 | $65 |
| Avion Pharmaceuticals | 4 | $62 |
| Eisai Inc. | 4 | $56 |
| Avanir Pharmaceuticals, Inc. | 3 | $53 |
| Pfizer | 3 | $50 |
| Johnson & Johnson | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Boehringer Ingelheim | 2 | $46 |
| Ironwood Pharmaceuticals, Inc | 2 | $45 |
| Abbott | 2 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| GSK | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Amgen | 2 | $32 |
| Mylan Specialty L.p. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 2 | $27 |
| Echosens North America, Inc. | 1 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $23 |
| Biogen | 1 | $23 |
| Ardelyx, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 2 | $19 |
| Astellas Pharma US Inc | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$126
How this compares
$2,897 in reported general payments places this provider in the 90th percentile of 158 women's health providers in North Carolina.
Other women's health in Asheboro
- Meredith HarrisRaleigh$241K
- Jami ChrzanowskiGreensboro$27K
- Amy KemmerlinCharlotte$8K
- Kylie CajkaCharlotte$5K
- Lindsey MosleyCharlotte$5K
- Lanika WrightGreenville$3K
- Melinda DavesHickory$3K
- Margaret DarstRaleigh$3K
- Kristin AllisonRaleigh$3K
- Tiffany MoonPlymouth$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.